Damora Therapeutics, Inc. (DMRA)

CIK 1800315 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Damora Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Aug 13, 202640001193125-26-349537
Aug 13, 202630001193125-26-349515
Aug 12, 2026EFFECT9999999995-26-002630
Aug 10, 2026S-8 POS0001193125-26-342710
Aug 10, 2026S-8 POS0001193125-26-342672
Aug 10, 2026POSASR0001193125-26-342717
Aug 10, 2026S-8 POS0001193125-26-342677
Aug 10, 2026S-8 POS0001193125-26-342687
Aug 10, 2026S-8 POS0001193125-26-342663
Aug 10, 2026S-8 POS0001193125-26-342698
Aug 10, 2026S-8 POS0001193125-26-342730
Aug 10, 2026S-8 POS0001193125-26-342737
Aug 10, 2026POS AM0001193125-26-342562
Aug 10, 20268-A12B/A0001193125-26-342406
Aug 10, 202610-Q0001193125-26-342307
Aug 6, 20261440001970051-26-000018
Jul 28, 2026SCHEDULE 13G0002012383-26-002507
Jul 20, 20268-K0001193125-26-308899
Jul 7, 202640001193125-26-297818
Jun 22, 20261440001970051-26-000017
Jun 17, 20268-K0001193125-26-274093
May 15, 2026SCHEDULE 13G/A0000919574-26-003477
May 15, 2026SCHEDULE 13G0000902664-26-002463
May 15, 2026SCHEDULE 13G/A0000902664-26-002524
May 12, 202610-Q0001193125-26-219327